While most insurance plans cover Caris molecular testing, we have additional financial assistance programs that provide added financial flexibility for patients. Caris’ Compassionate Care Program assists uninsured patients who may not be able to afford out-of-pocket costs associated with our molecular profiling test.
Caris Molecular Intelligence® typically is reimbursed by insurance providers, as well as Medicare. The cost will differ among the various Caris Molecular Intelligence offerings, depending on the tumor profile offered, and the number of biomarkers analyzed and technologies used. We will perform the services ordered and deemed medically necessary by a physician, regardless of our network status.